GTHP Guided Therapeutics Reports Significant Reductions in Debt and Operating Expenses 52 Week Range 0.0003 - $0.0038 Parabolic SAR Higher Than Share Price for Guided Therapeutics (GTHP) https://bucknerbusinessdaily.com/parabolic-sar-higher-than-share-price-for-guided-therapeutics-gthp/230397/